Close Menu
Skip to main content
Google Tag Manager
GenomeWeb
360Dx
Precision Oncology News
*
*
Show password
Forgot your password?
Subscribe
Contains all of these words:
Business & Policy
Business News
Regulatory News
Reimbursement
Biomarkers
BRCA
EGFR
HER2
KRAS
BRAF
ROS1
ALK
PD-L1
Cancer Specialties
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Brain Cancer
Melanoma
Pediatric Cancer
Oncology Trends
Next-Generation Sequencing
Minimal Residual Disease
Microsatellite Instability Testing
Immunotherapy
Liquid Biopsy
Resources
Webinars
White Papers
Menu
Home
›
About Us
›
Our Staff
›
Allan Nixon
Allan Nixon
Director of Business Development, Premium Content
Phone Number
+1-212-651-5623
Email
anixon@genomeweb.com
Breaking
News
NICE Guidance Recommends Amgen's Blincyto for ALL Patients in Remission
Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug
Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer
AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan
Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program
Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication
